The University of Texas MD Anderson Cancer Center has been ranked the No. 1 hospital for cancer care in the nation by U.S. News & World Report's "Best Hospitals" survey.
Since the annual survey launched in 1990, MD Anderson has been named one of the top two cancer hospitals in the United States. It has ranked first 11 times in the past 14 years.
"We're honored by this tremendous national recognition, but the true measure of our success is the number of lives we've impacted with our care, research and support," said Ronald A. DePinho, M.D., president of MD Anderson. "We owe our gratitude to the more than 20,000 cancer fighters, including world-class faculty and nurses, and 1,000-plus volunteers working every day to end cancer for our patients and others around the world. Our culture of exceptional care and genuine caring is second to none."
Specialty rankings
Two subspecialties also were ranked highly in this year's survey. In the Ear, Nose and Throat specialty, MD Anderson's Head and Neck Surgery service was ranked No. 5, the same ranking as last year. In Gynecology, MD Anderson's Gynecologic Oncology and Reproductive Medicine service moved forward one ranking, coming in at No. 7.
These specialty rankings are particularly notable because they include care provided at general hospitals across the nation, not just cancer centers. Both of these specialties have been consistently ranked high for the past two decades.
The survey also named MD Anderson as "high performing" in Urology, meeting the survey's standards for excellence.
"We're particularly proud of the efforts of our clinical team which contributed so much to MD Anderson achieving this," said Thomas Buchholz, M.D., executive vice president and physician in chief. "This recognition is a direct result of their constant dedication to the patients and families who come through our doors every day."
Events of Fiscal Year 2015
Last year, more than 127,000 people came to MD Anderson for innovative care, prevention services, clinical trials, diagnostics, second opinions and consults at survivorship clinics.
More than 8,000 participants were enrolled in clinical trials available through MD Anderson's Texas Medical Center campus and many of the locations and affiliations in its network.
MD Anderson's reach continues to expand, with the additions of partner member hospital Baptist MD Anderson Cancer Center in Jacksonville, Florida and international associate member Hospital Israelita Albert Einstein in Sao Paulo, Brazil.
In the Houston area, MD Anderson Diagnostic Imaging - West Houston opened in 2014, offering a full complement of screening and diagnostic services for any patient diagnosed with cancer or concerned about a suspicious lump.
The institution also joined with Memorial Hermann to provide collaborative imaging interpretation and consultation at its breast screening centers across the Houston area.
The new locations join established Houston-area clinics in The Woodlands, Bay Area, Sugar Land and Katy that provide specialized care, clinical trials and supportive services. An office in Memorial City is home to a surgery clinic where patients can go for consultations and follow-up appointments. MD Anderson also extends its broad spectrum of cancer care for patients at Lyndon B. Johnson Hospital, a part of Harris Health System.
Further extending reach across the United States and the world are partner members Banner MD Anderson Cancer Center with locations throughout the Phoenix region and MD Anderson Cancer Center at Cooper, based in Camden, New Jersey. There also are 12 certified member hospitals and health care systems in 10 states that employ MD Anderson clinical guidelines and best practices. MD Anderson has additional clinical programs in Madrid, Spain; Istanbul, Turkey; and Albuquerque, New Mexico.
Researchers uncover key genes linked to DCIS progression